StonvexLoading…
StonvexStonvexStonvexCore line items from ULH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.56B | $1.85B | $1.66B | $2.02B |
Operating Income | $-64.35M | $203.11M | $145.44M | $240.44M |
Net Income | $-99.87M | $129.91M | $92.90M | $168.63M |
EPS (Diluted) | $-3.79 | $4.93 | $3.53 | $6.37 |
Total Assets | $1.77B | $1.79B | $1.25B | $1.20B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $26.85M | $19.35M | $12.51M | $47.18M |
Free Cash Flow OCF − CapEx | $-41.13M | $-139.23M | $-30.31M | $96.31M |
Shares Outstanding | 26.33M | 26.32M | 26.28M | 26.28M |